<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 287 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page286.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=287">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 287 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 287</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=287"><img src="../thumb/287.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>250 / 2020-04                                                            Anti-Microbials - 18.10
   with tacrolimus, concom.meds.metab.by cytochrome P-450 syst., not   Fung.infect.prophylax.with concom.cytotox. chemo-/radiat.  prophylax.in pts.receiv.cytotox. chemother. &/radiat.ther., ac/recurr.
   indicat.for use in tinea capitis/ pulm.cryptococcos./cutan. cryptococ-  ther: 3-12 mg/kg dly.depend.on extent & durat.of induc.neutropen.  vag. candidiasis & prophylax.to reduc.recurr.incid., candidial balani-
   cos./ paracoccidioidomycos./ lymphocutan.sporotrichos. /histoplas-  Childr.und.2 wks: Use same mg/kg dos.as per paed. dos.specif.  tis, dermatomycos.incl.tinea pedis/ tinea corporis/ tinea cruris/tinea
   mos., admin.with caut.to pts with potent. pro-arrhythm.condits., incr.  above but admin.every 72 hrs. Childr.2-4 wks: Same dos.but every   unguium (onychomycosis) & derm.candida infects.
   risk of myopathy & rhabdomyolys. with concom. HMG-CoA reduct.   48 hrs. Max.adult dly dos.(ie.400 mg) not to be exceed.in childr.  Childr: Cryptococ.meningit.in ment.alert.pts. without localis.neu-
   inhibits., lact.intol./rare heredit.probl.of galact. intol./Lapp-lact.defic./  Contraindications: Known sens.to other azole antifung.agents,   rologic.signs.& as follow-up ther. aft.Amphotericin B ther., maint.
   gluc.-galact. malabsorpt.    pregn.& lactat., concom. astemizole / cisapride & terfenadine,   ther.to prev. cryptococ.dis.relapse in AIDS pts., system. candidias.,
   Interactions: Prolongs prothromb.time in warfar. ther., prolongs ser.  safety & effic.of caps.not est. in childr., IV infus.also: concom. ter-  oropharyngeal & oesophag.candidias., candidias. prophylax.in pts.
   half-life of oral sulphonylureas, incr. midazolam conc.partic.aft.oral   fenadine with multiple fluconazole dos.&gt; 400 mg/day, multipl.dos.  receiv.cytotox. chemother. &/radiat.ther.
   admin., multiple hydrochlorothiazide dos.incr.plasma conc., pheny-  ther.in ren. impairm.  (S4) CAPS, 38/20.2.2/0013, 0058, 0014
   toin/ rifabutin/tacrolimus plasma conc.incr., theophyll. clear.reduc.,   Side effects: Hepatotoxic., leucopen., neutropen., agranulocytos.,   704358-001: 50 mg, 14, R143,65
   rifampicin reduc.plasma conc., incr.zidovudine plasma conc., incr. ter-  thrombocytopen., headache, GI sympts., skin rash, dizzin., vertigo,   704357-001: 150 mg, 1, R27,35
   fenadine conc.follow.high dos. fluconazole assoc. with ECG abnor-  seiz., insomn., nervousn., rigors, fatig., malaise, hypokalaem., hy-  704357-003: 150 mg, 4, R109,41
   malit., card.arrhythm.with cisapride/ terfenadine, incr.plasma conc.of   percholesterolaem., hypertriglyceridaem., taste pervers., dyspeps.,   704356-001: 200 mg, 28, R508,38
   meds. metabol.by cytochrome P-450 syst., losartan effic. poss.decr.,   thirst, polyur., fem.sex.dysfunct., intermenst. bleed., leukorrh., men-  Dosage: Cont.ther.until lab.tests & clinic.paramet. indic.act.infect.
   alfentanil AUC incr., effect of amitriptyline/ nortriptyline incr., car-  orrhag., hepat.fail, hepatit., hepatocellul.necros., jaund., hyperton.,   subsid. Maint.ther.usually reqd.in AIDS pts.with cryptococc. menin-
   bamazepine/ fentanyl/ everolimus/sirolimus/methadone conc. incr.,   abnorm. vis., alopec., urticar., dry skin, abnorm.odour, exfoliat.cutan.  git/recurr. oropharyng. candidias.
   system.expos.of Ca.chann.antagons./ NSAIDs incr., C max and AUX of   reacts.eg.tox. epiderm.necrolys.& Stevens Johnson syndr., anaphy-  Adults:
   Celecoxib incr., incr. ser.bilirub. & ser.creatin.with cyclophosphamide.  lax.incl.angioed.  Cryptococ.meningit: Adults: 400 mg on 1st day, then 200-400 mg
   ASPEN FLUCONAZOLE, (Aspen Pharmacare: Pharma)   Special precautions: Monit.pts.receiv. concom. terfenadine with   dly depend.on clinic.respon.x8 wks.follow.Amphotericin B ther.& 10
                                fluconazole ther. &lt;400 mg/day if combinat.consid.essent., monit.
                                                              wks.on monother. Maint.in AIDS pts.to prev.relapse: 100-200 mg/day
   Pharmacare [P/S]             pts. on concom.warfar./sulphonylurea hypoglycaem. /theophyll.&   System.candidias: 1st day 400 mg, then 200 mg dly. Dos.may
   Fluconazole.                 nevirapine ther., imp. ren. funct., discont.ther.if rash develops, incr.   be incr.to 400 mg dly.depend.on clinic. respons.which also deter-
   Indications: 50 mg & 200 mg strengths: Cryptococ.meningit.,   uveit. risk with concom.rifabutin, underly.dis. such as AIDS/malign.,   min.durat.
   maint.ther.to prev. regress.cryptococ.dis.in AIDS pts., system. & oro-  because.IV infus.is dil. saline sol.consid.IV admin.rate in pts.requir.   Oropharyngeal candidias: 50-100 mg once dly.x7-14 days/
   pharyngeal candidias., prev.fung.infect in pts. at risk of such infects.  Na / fluid restrict. Caps: lact.intol.  long.in sev. immunocompris.pts. To prev.relapse in AIDS pts.ad-
                                  +
   due to cytotox.chemo-/ radiother.  Warnings: Monit.for more ser.hepat.injury if abnorm. liv.funct.tests   min.150 mg once wkly.
   150 mg strength: Dermatomycos incl.tinea pedis, tinea corporis,   develop & discont.if clinic. S&S of liv.dis.develop, AIDS pts.more sus-  Oesophag.candidiasis:  200 mg on 1  day follow. by 100-200 mg
                                                                              st
   tinea cruris, onychomycos. & derm. candida infects., vag.candidi-  cept.to cutan. reacts., discont.ther.when pts.with syst.fung. infects.  once dly.incr.upto 400 mg dly if no respons.aft.14 days on low.dos.
   asis, prophylax. of recurr. vag.candidias.  develop.bullous les./erythema multiforme, congenit.malformat.report   Treat for min.3 wks. & x2 wks.aft.sympt.resolv.
   (S4) CAPS, 37/20.2.2/0369, 0371, 0372.  with IV use dur.pregn., distribut.in breast milk at same conc.as plasma  Fung.infect.prophylax.in pts.receiv.cytotox. chemo-&/radiat.
   703623-001: 50 mg, 14, R141,95  Drug interactions: Incr.plasma conc.of meds. metabol. by cyto-  ther: 50-400 mg once dly.bas. on risk profile. Commenc. ther.sev.days
   703624-002: 150 mg, 1, R30,93  chrome P-450 system, plasma conc. of phenytoin/zidovudine/rifabu-  bef. anticipat.neutropen & contin.x7 days aft. neutrophil count rises
   703624-003: 150 mg, 4, R123,74  tin/ cyclosporin /warfarin/sulphonylurea hypoglycaem. /theophylline/  above 1000 cells per mm . 3
   703626-001: 200 mg, 28, R521,65  tacrolimus & nortriptyline incr., card.events incl.torsades de pointes.  Vag.candidiasis: 150 mg as sngl.dose.
   Dosage: Vag.candidiasis: 150 mg as sngl.oral dose.  with cisapride, incr.midazolam & triazolam conc.partic.aft.oral ad-  Recurr.vag.candidias: 150 mg once mnthly indiv.durat.which
   Candida balanitis: 150 mg as sngl.oral dos.  min., hydrochlorothiazide incr. fluconazole plasma conc., rifampicin   range from 4-12 mnths.
   Tinea pedis, corporis, cruris: 150 mg once wkly.x2-4 wks. but up   decr.fluconazole conc., nevirapine expos.incr.100%, OC effic.decr.,   Candida balanitis: 150 mg as sngl.dos.
   to 6 wks.for tinea pedis.    serious dysrhythm.report.with other azole antifung. and terfenadine.  Derm.infects.eg.tinea pedis, corporis, cruris and candida in-
   Tinea unguium/ onychomycos.: 150 mg once wkly.till nail re-  fects: 150 mg once wkly.x2-4 wks. but up to 6 wks.for tinea pedis.
   growth, fingernails: 3-6 mnths., toenails: 6-12 mnths.   AURO FLUCONAZOLE, Aurobindo [P/S]  Tinea unguium: 150 mg once wkly.x3-12 mnths until nail com-
   Cryptococ.meningit: 400 mg on 1st day, then 200 mg dly x6-8 wks,   Fluconazole  pletely replac.
   may be incr.to 400 mg dly. depend.on respon.  Indications: Adults: Cryptococ. meningit.& maint. ther.to prev.  Children:
   System.candidias: 1st day 400 mg, then 200 mg dly. Durat.de-  cryptococ.dis.relapse in syst. candidias./ oropharyng.& oesophag.  Do not exceed.max.adult dly dos. Admin.as sngl. dly.dos.
   pend.on clinic.respons.      candidias./ fung. infect.prevent.in pts.with malign.who are predispos.  Cryptococc.meningit.& system.candidias: Childr.over 4 wks:
   (S4) IV INFUS, [P/S] A39/20.2.2/0572. 2 mg/ml.  to such infects.aft.receiv.cytotox.chemo and radiother.  6-12 mg/kg/day depend.on severity.
   715057-001: 200 ml, 10, R1 597,01  (S4) CAPS, 43/20.2.2/0562, 0563  Oropharyngeal candidias: Childr.over 4 wks: Init.6 mg/kg on 1   st
   Indications: Adults & childr: Cryptococ. meningit. in ment..alert   721667-001: 150 mg, 1, R22,64  day follow.by 3 mg/kg once dly. x2 wks.at least to decr.relapse risk.
   without localis. neurologic. signs & as follow-up ther.aft. Ampho-  720661-001: 200 mg, 30, R378,33  Oesophag.candidias: Childr.over 4 wks: 6 mg/ kg on 1  day fol-
                                                                                      st
   tericin B ther., maint.ther.to prev. cryptococ. dis.relapse in AIDS pts.,   Dosage: Dos.& durat.bas.on site of infect.& indiv. respons.to ther.   low.by 3 mg/kg once dly.with dos. of upto 12 mg/kg/day accord.to
   system./ oropharyngeal & oesophag.candidias., fung. infect. prev.  Cont.ther.unt.clinic.paramet.& lab. tests indic.act.infect.subsid.   pt.respons. Treat for min.3 wks.& x2 wks.aft.sympt.resolv.
   dur.cytotox.chemo-/radiother.  Maint.ther.reqd.in AIDS pts.with cryptococc.meningit/recurr. oro-  Fung.infect.prophylax.in pts.receiv.cytotox. chemo-/radiat.
   Adults only: Ac./recurr.vag.candidiasis.& prophylax. to reduc.re-  pharyng. candidias.  ther: Childr.over 4 wks: 3-12 mg/ kg dly.depend.on extent & du-
   curr.infects.incid., candid. balanit., dermatomycos., onychomycos.,   Cryptococ.meningit: Adults: Init.400 mg on 1st day, then 200-  rat.of induc. neutropen.
   derm. candida infects.       400 mg dly.depend.on clinic. respons. Durat.usual.6-8 wks. Re-  Use in childr.4 wks.& younger: Infts.und. 2 wks: Use same mg/
   Dosage: Cont.ther.until lab.tests & clinic. paramet. indic.act.in-  lapse prevent.in AIDS pts: Admin.dly.dos.of 100-200 mg aft.full   kg dos.as for older childr.but admin.every 72 hrs. Wks.2-4: Same
   fect.subsid. Maint.ther. usually reqd.in AIDS pts.with cryptococc.   course of prim.ther.  dos.but every 48 hrs.
   meningit. /recurr.oropharyng.candidias. Infus. may be infus.at max.   System.candidias: Adults: 1st day 400 mg, then 200 mg dly. Dos.  Contra-indications: Hypersens.to other azole antifung. agents,
   rate of 200 mg/hr.with compat. admin.fluid. Mix.with any other   may be incr.to 400 mg dly.depend. on clinic.respons.  concom.terfenadine with multiple fluconazole dos.&gt;400 mg/day,
   drugs not recomm.            Oropharyngeal candidias: Adults: 50-100 mg once dly.x7-14 days/  concom.cisapride & astemizole, pregn.& lactat., multiple dos.ther.
   Adults:                      long.in sev.immunocomprom. pts. Relapse prevent.in AIDS pts:   in ren. impairm.
   Cryptococ.meningit: 400 mg on 1st day, then 200-400 mg dly   150 mg once wkly. aft.full course of prim.ther.  Side-effects: Bld.dyscras., CNS effs., hypokalaem., hypercholes-
                                                   st
   depend.on clinic.respon. x8 wks. follow.amphotericin B ther/x10   Oesophag.candidias.: Adults: 200 mg on 1  day follow. by 100-200   terolaem., hypertriglyceridaem., GI disturbs., taste pervers., thirst,
   wks as monother.             mg once dly. Dos.up to 400 mg/ day may be used based on pt.respons.   fem.sex.dysfunct., intermenst.bleed., menorrhag., leukorrh., polyuria,
                                Treatm.for min.of 3 wks.& for at least 2 wks follow.sympt. resolut.
   Maint.ther.to prev.cryptococ.meningit. relapse in AIDS pts:   hepatotox., hyperton., abnorm.vis., rash, alopec., allerg.reacts. incl.
   100-200 mg dly.              Candidias.prevent: 50-400 mg once dly.based on pt.risk for devel-  anaphylax./Stev.-Johnson syndr.& tox. epiderm. necrolys.
                                op.fung.infects. Pts.at high risk for syst.infects: 400 mg once dly.
   System.candidias: 1st day 400 mg, then 200 mg dly.poss.incr.  Special precautions: AIDS pts.more suscept.to cutan. reacts.,
   to 400 mg dly depend.on clinic. respons. Durat.depend.on clinic.&   Start sever. days bef.anticip.neutropen.onset & cont.for 7 days aft.  discont.ther.when pts.with syst. fung.infects.develop.bullous les./
                                neutroph.count rises above 1 000 cells/mm .
                                                  3
   mycolog. respons.                                          erythema multiforme, essent.to monit.terfenadine conc.if admin.con-
   Oropharyngeal candidias: Recomm.dos: 50-100 mg once dly.x7-  Contraindications: Safety in pregn.not est., lactat., multip.dos.ther.  com.with fluconazole dos.&lt;400 mg/day, incr.uveit.risk with rifabutin,
                                in ren.impairm., concom. meds. metab.by CYP 3A4/known to prolong
   14 days/long.in sev. immunocompris. pts. To prev.relapse in AIDS   QT interv., lact.intol., not suit.for dos.&lt; 50 mg/kg, concom. cisapride.  passes into breast milk, congenit.malformat.report., imp.ren.funct.,
   pts: 150 mg once wkly.       Side effects: Bld.dyscras., anaphylax., angioed., hypertriglyceri-  monit.liv.funct., underly.AIDS/malign.
   Oesophag.candidiasis: 200 mg on 1  day follow. by 100-200 mg   daem., seiz., GI disturbs., hepatit., liv.fail., skin reacts.incl.Stev.Johns.  Warnings:  Monit.pts.develop.abnorm.liv.funct. for more seri-
                   st
   once dly.with dos.of upto 400 mg dly. if no clinic.respons.aft.14 days.   ous hepat.injur.
   Treat for min.3 wks.& x2 wks.aft.sympt.resolut.  syndr./tox. epiderm.necrolys., alopec., menstr.disords., abnorm. vis.  Drug interactions: Incr.plasma conc.of meds. metabol. by cy-
                                Warnings and special precautions: Passes into breast milk, ren.
   Fung.infect.prophylax.with concom.cytotox. chemo-/radiat.  tochrome P-450 syst., prolongs prothromb. time in warfarin ther.,
   ther: 50-400 mg once dly.bas. on risk profile. Commenc.ther.sev.days   impairm.esp.in elderly, monit. pts. develop. abnorm.liv.funct.for more   incr.plasma conc. of oral sulphonylureas, phenytoin/rifabutin/ tac-
                                ser.hepat. injur. prim.seen in pts.with ser.underly.med. condits., dis-
   bef.anticipat. neutropen & contin.x7 days aft.neutrophil count rises   rolimus/zidovudine/ciclosporin plasma conc. incr., theophyll.clear.
   above 1000 cells per mm 3    cont.when clinic.S&S of liv.dis.devel. poss. attribut.to ther./when pts.  reduc., life threaten.card. arrhythm.with cisapride, incr.midazolam
                                with invas./syst. fung. infects.devel.bullous les./erythema multiforme,
   Vag.candidiasis: 150 mg as sngl.dos.                       & triazolam conc.partic.aft.oral admin., hydrochlorothiaz. incr.flu-
   Recurr.vag.candidiasis: 150 mg as sngl.dos. mnthly. Indiv.durat.  concom.warfar.esp.dur.surg./ dent. proced., concom.benzodiazepin./  conazole plasma conc., rifampicin reduc.fluconazole plasma conc.,
                                cyclospor./ rifabutin/nevirapine/zidovudine, monit.poss. nephro-/neu-
   but ranges from 4-12 mnths.  rotoxic.with tacrolimus, poss. theophyll. toxic.  expos. to nevirapine incr.
   Candida balanitis: 150 mg as sngl.dos.  Drug interactions: Prolongs prothromb.time in warfarin ther., incr.
   Dermatomycos.incl.T.pedis/T.corporis/T.cruris, onychomy-  midazolam conc.esp.aft.oral fluconazole, ser.half-life of oral sulphony-  BINACIL, Aurobindo [P/S]
   cos., derm.candida infects: 150 mg as sngl.dos.wkly. Treatm.  lur.incr., incr. plasma conc.with hydrochlorothiaz., incr. phenytoin lev.,   Terbinafine HCl.
   durat.usually 2-4 wks., tinea pedis up to 6 wks. Tinea unguium cont.  ser.life threat. card.arrhythm.incl. torsades de pointes with cisapride,   Indications: Fung.skin infect.caus.by Trichophyton, Microsporum
   until infect.nail grows out & is replac. Fingernails: 3-6 mnths & toe-  incr.rifabutin/ tacrolimus ser.lev., incr.plasma conc.of meds. metabol.   canis & Epidermophyton floccosum, ringworm where oral ther. ap-
   nails 6-12 mnths.            by cytochrome P-450 syst., theophyll. clear. reduc., rifampicin decr.flu-  propr.due to site/sev.of infect., onychomycos.
   Childr.over 4 wks.of age:    conazole AUC & half-life, incr.nevirapine expos., incr.zidovudine AUC.  (S4) TABS. 42/20.2.2/0472
   System.candidias.& cryptococc.meningit: 6-12 mg/kg/day de-  722724-001: 250 mg, 14, R303,72
   pend.on severity and clinic.& mycologic.respons.  AUSTELL-FLUCONAZOLE, Austell [P/S]  Dosage: 250 mg once dly. Tinea pedis: 2-6 wks., T corporis: 4 wks,
   Oropharyngeal candidias: 6 mg/kg on 1  day follow.by 3 mg/kg   Fluconazole.  T cruris: 2-4 wks. In onychomycos. treat for 6 wks.-3 mnths. Childr:
                     st
   once dly.x2 wks.at least to decr. likelihood of relapse.  Indications: Adults: Cryptococ.meningit.in ment. alert.pts.with-  Data limit.theref. not recomm.
   Oesophag.candidias: 6 mg/kg on 1  day follow. by 3 mg/kg once   out localis.neurologic. signs. & as follow-up ther.aft.Amphotericin   Contraindications: Imp.liv.funct., safety in pregn. & lactat.not est.
                  st
   dly.with dos.of up to 12 mg/kg/ day accord.to pt.respons. Treat for   B ther., maint.ther. to prev.cryptococ.dis. relapse in AIDS pts., sys-  Side effects: GI disords., taste loss & disturb., headache, psych.
   min. 3 wks.& x2 wks.aft.sympt.resolut.  tem. candidias., oropharyngeal & oesophag. candidias., fung.infect.  disturbs., para-/hypoaesthes., dizzin., vertigo, malaise, fatig., skin</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page286.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page282.html">282</a>&nbsp;&nbsp;&nbsp;<a href="page283.html">283</a>&nbsp;&nbsp;&nbsp;<a href="page284.html">284</a>&nbsp;&nbsp;&nbsp;<a href="page285.html">285</a>&nbsp;&nbsp;&nbsp;<a href="page286.html">286</a>&nbsp;&nbsp;&nbsp;<a href="page287.html">287</a>&nbsp;&nbsp;&nbsp;<a href="page288.html">288</a>&nbsp;&nbsp;&nbsp;<a href="page289.html">289</a>&nbsp;&nbsp;&nbsp;<a href="page290.html">290</a>&nbsp;&nbsp;&nbsp;<a href="page291.html">291</a>&nbsp;&nbsp;&nbsp;<a href="page292.html">292</a>
             </td>
             <td width="35%"><a href="page288.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page288.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
